ADORA2A and Parkinson disease: In contrast to targeting the hippocampus cortex by cholinesterase and NMDA inhibitors, the selective localization of A2AR in the striatopallidal pathway would provide a novel and promising target for selectively alleviating cognitive deficits in PD.